Portal de investigación
DOTMASK. Estudio para el desarrollo de Equipos de Protección Individual mejorados con capacidades antimicrobianas
Datos básicos
- Código:
- INNEST/2021/260
- Protocolo:
- INNEST/2021/260
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- 121.517,00 €
- Año de incio:
- 2021
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A surface plasmon resonance based approach for measuring response to pneumococcal vaccine.
Garrido-Jareño M; (...); Pineda-Lucena A
Article. 10.1038/s41598-021-85958-0. 2021
AmBisome, three challenges: Candida auris infection, central nervous system infection, and biofilm-associated infection
Ruiz-Gaitan, A, del Pozo, JL
Article. 10.1016/j.riam.2021.03.004. 2021
Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.
Garcia-Bustos, Victor; (...); Peman, Javier
Article. 10.1016/j.cmi.2023.03.016. 2023
Clonal Evolution Analysis Using Next Generation Sequencing (NGS) Panel in a Cohort of 3,025 Patients With Acute Myeloid Leukemia (AML)
Colmenares, Rafael; (...); Montesinos, Pau
Meeting Abstract. 2023
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
Sargas, Claudia; (...); Montesinos, Pau
Article. 10.1038/s41408-023-00835-5. 2023
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Interim Analysis of the PCR-LMA Protocol of the Pethema Group
Boluda, Blanca; (...); Montesinos, Pau
Meeting Abstract. 10.1182/blood-2022-160136. 2022
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; (...); Pemán J
Article. 10.1128/Spectrum.00013-21. 2021
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry.
Zvezdanova ME; (...); Vicente D
Article. 10.1016/j.cmi.2021.06.005. 2022
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Moreno-Garcia, E; (...); Garcia-Vidal, C
Article. 10.1093/ofid/ofab250. 2021
Enhanced Antibacterial Activity through Silver Nanoparticles Deposited onto Carboxylated Graphene Oxide Surface
Barjola, Arturo; (...); Gimenez, Enrique
Article. 10.3390/nano12121949. 2022
Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain
Vazquez, Roberto; (...); Garcia, Pilar
Review. 10.3390/microorganisms10040717. 2022
Evolution of the Genetic and Biological Studies Performed at Diagnosis in Patients with Acute Myeloid Leukemia Included in the Pethema Epidemiological Registry (REALMOL Study)
Labrador, Jorge; (...); Manuel Alonso-Dominguez, Juan
Meeting Abstract. 10.1182/blood-2022-163016. 2022
Filamentous fungi in the airway of patients with cystic fibrosis: Just spectators?
Vinado, Clara; (...); Sole, Amparo
Article. 10.1016/j.riam.2021.03.005. 2021
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials.
Gonzalez-Gil, Celia; (...); Genesca, Eulalia
Article. 10.3324/haematol.2022.281196. 2023
-
-
-
PlumX Metrics
- Citations
- Citation Indexes: 5
- Policy Citations: 1
- Captures
- Readers: 27
- Mentions
- News Mentions: 2
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.
Serrano-Lobo J; (...); ASPEIN Study Group
Article. 10.1111/myc.13541. 2022
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
Human papilloma virus DNA detection in clinical samples using fluorogenic probes based on oligonucleotide gated nanoporous anodic alumina films.
Hernández-Montoto A; (...); Martínez-Máñez R
Article. 10.1002/adhm.202203326. 2023
IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients.
Vallejo, Carlos; (...); Peman, Javier
Article. 10.3390/jof9060628. 2023
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1007/s00430-022-00759-0. 2023
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia
Claverias, L.; (...); Rodriguez, A.
Article. 10.1016/j.medin.2021.12.005. 2022
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia.
Claverias L; (...); Rodríguez A
Article. 10.1016/j.medine.2021.12.013. 2022
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols.
Barba P; (...); Ribera JM
Article. 10.1097/HS9.0000000000000810. 2023
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
Ayala, Rosa; (...); Montesinos, Pau
Article. 10.3390/cancers14235799. 2022
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Kayser, Sabine; (...); Schlenk, Richard F.
Article. 10.3324/haematol.2022.282127. 2023
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Quindós G; (...); Eraso E
Article. 10.3389/fcimb.2022.906563. 2022
In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris.
Caballero U; (...); Jauregizar N
Article. 10.3390/pharmaceutics13111767. 2021
Individualized antifungal therapy in critically ill patients with invasive fungal infection
Zaragoza, R, Maseda, E, Peman, J
Article. 10.1016/j.riam.2021.04.006. 2021
Indolent Acute Myeloid Leukemia with Long Survival in Patients Treated with Best Supportive Care Only: A Pethema Registry Study
Labrador, Jorge; (...); Montesinos, Pau
Meeting Abstract. 10.1182/blood-2022-162591. 2022
Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.
Ibáñez-Martínez E; (...); Pemán J
Case Reports. 10.1016/j.riam.2021.06.002. 2021
Lack of evidence for infectious SARS-CoV-2 in feces and sewage
Albert, Sandra; (...); Domingo-Calap, Pilar
Article. 10.1007/s10096-021-04304-4. 2021
-
-
-
PlumX Metrics
- Citations
- Citation Indexes: 33
- Policy Citations: 2
- Captures
- Readers: 56
- Mentions
- News Mentions: 1
Liposomal amphotericin B: thirty years of a highly effective therapy for the treatment of invasive mycoses
Peman, J, Quindos, G
Editorial Material. 10.1016/j.riam.2021.04.007. 2021
Long-term antibacterial Ag plus -release biomaterials based on anodized Ti6Al4V and silver nanoparticles
Molina, J.; (...); Tormo-Mas, M. A.
Article. 10.1016/j.colsurfa.2023.132243. 2023
Microbiological assessment of arterial allografts processed in a tissue bank
Mirabet, V.; (...); Peman, J.
Article. 10.1007/s10561-021-09951-7. 2021
Microstructural, mechanical, electrochemical, and biological studies of an electron beam melted Ti-6Al-4V alloy
Romero-Resendiz, L.; (...); Amigo-Borras, V
Article. 10.1016/j.mtcomm.2022.103337. 2022
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Sargas, Claudia; (...); On Behalf Of Pethema Group
Article. 10.3390/cancers15020438. 2023
Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Candida auris Clades: In Vitro and In Vivo Assays.
Marena, Gabriel Davi; (...); Peman, Javier
Article. 10.3390/microorganisms11071626. 2023
Non-Invasive Infections Diagnosis in Lung Transplant Recipients in Exhaled Breath Condensate
Ibanez-Martinez, E.; (...); Sole-Jover, A.
Meeting Abstract. 2021
Novel Chromogenic Medium CHROMagar TM Candida Plus for Detection of Candida auris and Other Candida Species from Surveillance and Environmental Samples: A Multicenter Study.
Mulet Bayona, Juan Vicente; (...); Gimeno Cardona, Concepcion
Article. 10.3390/jof8030281. 2022
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Martinez-Cuadron, David; (...); Montesinos, Pau
Article. 10.3324/haematol.2022.282506. 2024
Pethema NGS-AML Project. Final Analysis and Clinical Validation of New Genomic Classifications
Sargas, Claudia; (...); Montesinos, Pau
Meeting Abstract. 10.1182/blood-2022-166639. 2022
Prognostic Impact of NPM1 and FLT3-ITD Mutations in Patients Treated with Non-Intensive Regimens: A Pethema Registry Study
Uriel Suarez, Edwin; (...); Montesinos, Pau
Meeting Abstract. 10.1182/blood-2022-167365. 2022
Radical genome remodelling accompanied the emergence of a novel host-restricted bacterial pathogen
Yebra, G; (...); Penades, JR
Article. 10.1371/journal.ppat.1009606. 2021
Risk assessment of arterial allograft contamination from tissue donors colonized by Candida auris.
Mirabet V; (...); Pemán J
Article. 10.1016/j.jhin.2021.03.003. 2021
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
Pinana, Jose Luis; (...); Solano, Carlos
Article. 10.1038/s41409-023-01946-0. 2023
Supervised Machine Learning Improves Risk Stratification in Newly Diagnosed Myelodysplastic Syndromes: An Analysis of the Spanish Group of Myelodysplastic Syndromes
Mosquera Orgueira, Adrian; (...); Valcarcel, David
Meeting Abstract. 10.1182/blood-2022-159429. 2022
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.
Villar, Sara; (...); Montesinos, Pau
Article. 10.3389/fonc.2022.1054458. 2022
Transcriptional and Genomic Characterization of Measurable Residual Disease (MRD) Cells in Acute Myeloid Leukemia (AML)
Patricia Simoes, Catia; (...); Paiva, Bruno
Meeting Abstract. 10.1182/blood-2022-163159. 2022
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Simoes, Catia; (...); Montesinos, Pau
Letter. 10.1111/bjh.18815. 2023
Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021
Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021
Usefulness of Chromogenic Media with Fluconazole Supplementation for Presumptive Identification of Candida auris.
Ruiz-Gaitan, Alba; (...); Peman, Javier
Article. 10.3390/diagnostics13020231. 2023
What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.
Garcia-Bustos V; (...); Pemán J
Article. 10.3390/microorganisms9102177. 2021
WHO and ICC 2022 Cytogenetic Abnormalities Defining Acute Myelogenous Leukemia (AML) Myelodysplasia-Related in First-Line Decitabine in Unfit AML Patients
Ortiz Lopez, Alicia; (...); de la Fuente Burguera, Adolfo
Meeting Abstract. 2023